Apply to be a speaker

Home > Apply to be a speaker

Apply to be a Speaker or submit a Poster

Your insight, experience and participation as a valued customer are incredibly important to us, and this meeting is a wonderful opportunity to connect with other customers using OncoDNA’s products and our teams.

It’s easy to submit your speaker or poster ideas linked to our User Group topics. Just complete the form by the 14th of January 2026.

Click here

WHY BE A SPEAKER?

As a valued presenter at User Group, you will:

Build on leadership and public speaking skills outside of your daily job function

Share expertise and success stories positioning yourself as a leader, enhancing your professional standing

Connect with peers, industry experts, and collaborators internationally who share similar challenges and interests.

Expand your knowledge as presenting and inviting feedback from others can provide new perspectives, innovative ideas, and solutions that might not have been otherwise considered.

Access support for travel and accommodation* to help you cover the costs of attending User Group.

* The approximate cost of your flight including which airport you will fly from to Valencia and which airline.  Also state if you will require one- or two-nights accommodation
Please note OncoDNA will review these requests on a ‘case by case basis’</span

VERBAL PRESENTATION OR POSTER?

We welcome presenters both verbal and via poster who can contribute to the following topics.
There is no limit to the number of submissions you make or topics you wish to present/submit posters

Topics

1. Liquid Biopsy or Tissue NGS Testing in Oncology – Competing Options or a Complimentary Strategy?  

Included but not limited to presentations relating to the choice of liquid or solid kits available for laboratories to buy, what criteria was used to shortlist and then what influenced the final decision to use OncoDNA’s kits (solid or liquid or both).Descriptions of the experience of implementing OncoDNA’s kits.  This could include aspects of validation, logistics, sensitivity, reporting etc. As well as the clinical applications, specific targets such as HRD and the local testing strategy is it liquid or tissue or both?

Included but not limited to presentations relating to the how OncoDEEP or OncoSELECT or both are enabling research projects. Describe the questions the research is aiming to answer, what patient groups/cancer types will benefit, set out the current position of the research project and the findings to date.  Highlight if the project will continue and why or if there is a finite end to the project.  Include where it is expected the findings will be published in the wider context.  g. conferences, journals etc.

Included but not limited to presentations relating to the NGS strategy of your laboratory or country. Describe what is driving the uptake of WES beyond CGP?  And the different applications in precision oncology that are best satisfied by CGP and WES.  Describe the challenges and opportunities of reporting and handling data when delivering WES as compared to CGP.

Included but not limited to presentations that identify the different practices customers have used to evidence the quality of CGP testing enabled by OncoDEEP and OncoSELECT kits. Descriptions of quality goals, findings, improvements made (if any) as well as certifications achieved and how ongoing monitoring of quality is managed within the wider regulatory context in which the customer works. (noting that regulation will be different from country to country)

Included but not limited to presentations that showcase the role of bioinformaticians working in smaller as well as larger laboratories and in both research and clinical diagnostic settings.  Presentations should describe the regulatory requirements that need to be satisfied in the speaker’s country. The experience of using OncoDNA’s software, data storage and how integration, insights and reporting are managed. Challenges and opportunities of the bioinformaticians role should be explored given the data generated is ultimately used as a basis for interpreting genomic findings by clinicians.  

Included but not limited to addressing distinct aspects of the OncoDEEP and OncoSELECT workflow that can be automated using different sequencers and robotics to improve quality and productivity and reduce costs. Presentations might include high level automation plans, training plans and outline the benefits already realised and highlight those still being worked towards.

Included but not limited to addressing distinct aspects of the OncoDEEP and OncoSELECT workflow that can be automated using different sequencers and robotics to improve quality and productivity and reduce costs. Presentations might include high level automation plans, training plans and outline the benefits already realised and highlight those still being worked towards.

Please note speakers are not required for this topic as all registered delegates will be invited to submit to this live Q&A when registering for User Group

How to apply ?

Nothing easier, just fill in the form, share presentation or poster details and we will get back to you early January.

Name
Use this field to explain the questions/problems/opportunities being addressed in your presentation, outline your key points and learnings. Summarise the results, impact and what’s next. Confirm that you will seek to use data (quantitative and qualitative) to evidence as many points in your presentation as possible, (Yes/No)
A short summary of the speakers background and experience (no more than four sentences).

At OncoDNA, we take your privacy very seriously. We will process and use the information supplied above to contact you with the information requested and to provide you with relevant details about this event and future editions of this and other similar events/products that we think may be of interest to you. We will only ever use the information we collect or receive about you in accordance with our Privacy Policy .